1. A novel series of N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amines as highly potent CDK4/6 inhibitors. (September 2017) Authors: Tadesse, Solomon; Zhu, Ge; Mekonnen, Laychiluh B; Lenjisa, Jimma L; Yu, Mingfeng; Brown, Michael P; Wang, Shudong Journal: Future medicinal chemistry Issue: Volume 9:Number 13(2017) Page Start: 1495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer. Issue 3 (6th March 2023) Authors: Wittwer, Nicole L; Staudacher, Alexander H; Liapis, Vasilios; Cardarelli, Pina; Warren, Harriet; Brown, Michael P Journal: Journal for immunotherapy of cancer Issue: Volume 11:Issue 3(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma. Issue 8 (11th August 2021) Authors: Brown, Michael P; Ebert, Lisa M; Gargett, Tessa Journal: Clinical & translational immunology Issue: Volume 10:Issue 8(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical chimeric antigen receptor‐T cell therapy: a new and promising treatment modality for glioblastoma. Issue 5 (20th May 2019) Authors: Brown, Michael P; Ebert, Lisa M; Gargett, Tessa Journal: Clinical & translational immunology Issue: Volume 8:Issue 5(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Issue 5 (May 2018) Authors: Long, Georgina V; Atkinson, Victoria; Lo, Serigne; Sandhu, Shahneen; Guminski, Alexander D; Brown, Michael P; Wilmott, James S; Edwards, Jarem; Gonzalez, Maria; Scolyer, Richard A; Menzies, Alexander M; McArthur, Grant A Journal: Lancet oncology Issue: Volume 19:Issue 5(2018) Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Complete response to immunotherapy in a nonagenarian patient with metastatic melanoma. Issue 7 (22nd July 2020) Authors: Foo, Tiffany; Tapia Rico, Gonzalo; Brown, Michael P Journal: BMJ case reports Issue: Volume 13:Issue 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?. Issue 3 (17th March 2017) Authors: Tan, Lih Yin; Martini, Carmela; Fridlender, Zvi G; Bonder, Claudine S; Brown, Michael P; Ebert, Lisa M Journal: Clinical & translational immunology Issue: Volume 6:Issue 3 (2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Could bystander killing contribute significantly to the antitumor activity of brentuximab vedotin given with standard first-line chemotherapy for Hodgkin lymphoma?. (April 2014) Authors: Brown, Michael P; Staudacher, Alexander H Journal: Immunotherapy Issue: Volume 6:Number 4(2014:Apr.) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Current and emerging immunotherapeutic approaches to treat and prevent peanut allergy. (December 2012) Authors: Miller, Darren S; Brown, Michael P; Howley, Paul M; Hayball, John D Journal: Expert review of vaccines Issue: Volume 11:Number 12(2012) Page Start: 1471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy. Issue 10 (14th October 2020) Authors: Ebert, Lisa M; Yu, Wenbo; Gargett, Tessa; Toubia, John; Kollis, Paris M; Tea, Melinda N; Ebert, Brenton W; Bardy, Cedric; van den Hurk, Mark; Bonder, Claudine S; Manavis, Jim; Ensbey, Kathleen S; Oksdath Mansilla, Mariana; Scheer, Kaitlin G; Perrin, Sally L; Ormsby, Rebecca J; Poonnoose, Santosh;... Journal: Clinical & translational immunology Issue: Volume 9:Issue 10(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗